Search
Quick Filters
Clinical Trials Data
Showing 775 of 543136 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/26/19
End: 10/18/19
Due: 10/18/20
Phase: N/A
Priority: Normal
Start: 09/30/14
End: 05/31/15
Due: 05/31/16
Phase: N/A
Priority: Normal
Start: 08/31/21
End: 06/10/22
Due: 06/10/23
Phase: N/A
Priority: Normal
Start: 04/30/09
End: 10/31/09
Due: 10/31/10
Phase: N/A
Priority: Normal
Start: 12/31/06
End: 09/30/08
Due: 09/30/09
Phase: N/A
Priority: Normal
Start: 06/30/16
End: 02/28/17
Due: 02/28/18
Phase: N/A
Priority: Normal
Start: 09/09/20
End: 05/04/21
Due: 05/04/22
Phase: N/A
Priority: Normal
Start: 08/01/17
End: 10/30/17
Due: 10/30/18
Phase: N/A
Priority: Normal
Start: 05/21/21
End: 11/03/22
Due: 11/03/23
FLOX + Cetuximab (Erbitux®) for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS Tumor
Phase: N/A
Priority: Normal
Start: 04/30/08
End: 02/28/13
Due: 02/28/14
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 02/01/24
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 11/10/18
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 02/13/24
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 03/31/14
End: 08/31/23
Due: 08/31/24
Phase: N/A
Priority: Normal
Start: 03/21/22
End: 10/01/26
Due: 10/01/27
Phase: N/A
Priority: Normal
Start: 11/08/17
End: 01/12/21
Due: 01/12/22
Phase: N/A
Priority: Normal
Start: 05/28/21
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 12/28/22
End: 02/22/23
Due: 02/22/24
Phase: N/A
Priority: Normal
Start: 02/01/23
End: 11/30/25
Due: 11/30/26
Phase: N/A
Priority: Normal
Start: 12/31/03
End: 12/31/03
Due: 12/31/04
Phase: N/A
Priority: Normal
Start: 10/23/19
End: 01/04/23
Due: 01/04/24
Phase: N/A
Priority: Normal
Start: 06/30/24
End: 09/30/27
Due: 09/30/28
Phase: N/A
Priority: Normal
Start: 09/15/15
End: 05/30/17
Due: 05/30/18
Phase: N/A
Priority: Normal
Start: 02/25/25
End: 07/31/25
Due: 07/31/26